BIO Web Conf.
Volume 60, 20232022 4th International Conference on Biotechnology and Food Science (BFS 2022)
|Number of page(s)||7|
|Section||Biochemical Application and Genetic Engineering|
|Published online||11 May 2023|
Study on the Mechanism of Coptis Chinensis in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
1 Department of Health Management, CCUCM, CCUCM, Changchun, China
2 Department of Clinical Medicine, CCUCM, CCUCM, Changchun, China
3 Academic Affairs Office, CCUCM, CCUCM, Changchun, China
To investigate the therapeutic effects of Coptis chinensis on diabetic nephropathy using systematic pharmacological techniques. The TCMSP database was used to search the main components and related targets of Coptis chinensis; the GeneCards and CTD databases were used to screen the disease targets of diabetic nephropathy, and the intersection of the targets and disease targets was taken and plotted in Venn diagram; the target protein interaction (PPI) network was constructed from STRING database; the DAVID 6.8 online tool was used to GO and KEGG enrichment analyses were performed using DAVID 6.8 online tool to obtain the key signaling pathways of Coptis chinensis acting in diabetic nephropathy. Fourteen effective components of Coptis chinensis and 186 targets were obtained from the TCMSP database, and 3358 diabetic nephropathy targets were obtained from the summary of two databases, GeneCards and CTD. 118 intersecting targets of Coptis chinensis components and diabetic nephropathy diseases were obtained, and the core targets were TP53, MAPK1, AKT1, RELA, TNF, CAV1, RXRA, which may act on MAPK signaling pathway and PI3K-Akt signaling pathway to regulate the inflammatory response and oxidative stress generated by diabetic nephropathy process, thus reducing the disease symptoms. Coptis chinensis can exert its mechanism of action for the treatment of diabetic nephropathy through multiple components with multiple targets and pathways.
© The Authors, published by EDP Sciences, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.